Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
17.35
+0.32 (1.88%)
At close: Oct 13, 2025, 4:00 PM EDT
17.35
0.00 (0.00%)
After-hours: Oct 13, 2025, 5:37 PM EDT
Immunovant Market Cap
Immunovant has a market cap or net worth of $3.02 billion as of October 13, 2025. Its market cap has decreased by -27.29% in one year.
Market Cap
3.02B
Enterprise Value
2.42B
1-Year Change
-27.29%
Ranking
Category
Stock Price
$17.35
Market Cap Chart
Since June 21, 2019, Immunovant's market cap has increased from $124.38M to $3.02B, an increase of 2,331.68%. That is a compound annual growth rate of 65.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 2.97B | -18.35% |
| Dec 31, 2024 | 3.64B | -40.34% |
| Dec 29, 2023 | 6.09B | 165.79% |
| Dec 30, 2022 | 2.29B | 134.03% |
| Dec 31, 2021 | 979.80M | -78.33% |
| Dec 31, 2020 | 4.52B | 404.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 21, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 748.25B |
| Johnson & Johnson | 459.32B |
| AbbVie | 407.19B |
| UnitedHealth Group | 321.06B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 260.80B |
| Novartis AG | 253.85B |
| Abbott Laboratories | 230.73B |